high turnover, management is former Hologic people, 2 bad quarters you are done. competitor Tandem now has better product
It’s a little of both. Expanded 4x in 5 years. Also it’s a grind—weird mix between device and pharma with some DME mixed in. High growth expectations quarter over quarter.